1. Arbeeny CM, Meyers DS, Hillyer DE, Bergquist KE (1995) Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice. Am J Physiol 268(4 Pt 1):E678–E684
2. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S (1984) Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309(5964)163–165
3. Arch JRS, Bywater RJ, Coney KA, Ellis RDM, Thurlby PL, Smith, SA, Zed C (1989) Influences on Body Composition and Mechanism of Action of the β-Adrenoceptor Agonist BRL26830A. In: Lardy H, Stratman F (eds) Hormones, Thermogenesis, and Obesity. Elsevier Science Publishing Co., London, pp 465–475
4. Arch JRS, Wilson S (1996) Prospects for β3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes 20:191–199
5. Astrup A, Bulow J, Madsen J, Christensen NJ (1985) Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol 248(5 Pt 1):E507–E515